SCHEMBL30938873

SCHEMBL30938873

C=C1c2cc(N3CCN(C(=O)OCc4ccccc4)CC3)ccc2C(=O)N1C1CCC(=O)NC1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 9/20 0.55
▸ DDB1 Q16531 5/20 0.47
▸ HPGDS O60760 2/20 0.47
▸ TMEM97 Q5BJF2 10/20 0.44
▸ SIGMAR1 Q99720 10/20 0.44
▸ HRH2 P25021 4/20 0.44
▸ HRH1 P35367 4/20 0.44
▸ HRH3 Q9Y5N1 4/20 0.44
▸ HTR1A P08908 3/20 0.44
▸ ADRA2A P08913 3/20 0.44
▸ ADRA2B P18089 3/20 0.44
▸ HTR2C P28335 3/20 0.44
▸ HTR2A P28223 2/20 0.44
▸ HTR2B P41595 2/20 0.44
▸ DRD3 P35462 2/20 0.44
▸ CHRM4 P08173 1/20 0.44
▸ CHRM5 P08912 1/20 0.44
▸ ADRA1D P25100 1/20 0.44
▸ ADRA1A P35348 1/20 0.44
▸ ADRA1B P35368 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29927356 0.88 CRBN (0.57) CRBNDDB1HPGDSIKZF3
SCHEMBL29132159 0.88 CRBN (0.57) CRBNDDB1HPGDSIKZF3
SCHEMBL31043982 0.87 CRBN (0.58) CRBNDDB1HPGDSTMEM97SIGMAR1
SCHEMBL29927342 0.86 CRBN (0.55) CRBNDDB1HPGDSTMEM97SIGMAR1
SCHEMBL31043971 0.85 CRBN (0.56) CRBNDDB1HPGDS
SCHEMBL30683384 0.84 CRBN (0.56) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL27035713 0.84 CRBN (0.56) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL30683380 0.84 CRBN (0.56) CRBNDDB1HPGDSIKZF3ALDH1A1
SCHEMBL22291366 0.84 CRBN (0.54) CRBNDDB1HPGDSIKZF3
SCHEMBL29547197 0.84 CRBN (0.54) CRBNDDB1HPGDSTMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 — — EP disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 — — WO disclosed
Send feedback